RegulatoryAlerts Logo
RegulatoryAlerts
InsightsBlogPricingSign InStart Free Trial
All EMA (EU) updates
EMA (EU)
EVENT
Immunogenicity and efficacy of pneumococcal vaccines
Published: 11/16/2026Detected: 11/11/2026

Summary preview

Workshop output on immunogenicity and efficacy evidence for pneumococcal vaccines, with emphasis on how evolving pneumococcal epidemiology and expanding serotype coverage may require optimisation of development and…

Get the full analysis, free

Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.

Create free account
immunology
infectious_disease
pediatrics
respiratory
clinical
safety
quality
clinical
#pneumococcal conjugate vaccine
#PCV
#serotype coverage

Official Source Document
Source Verified

Access the original document directly from EMA.

View Official Document

More from EMA (EU)

  • Pharmacovigilance Risk Assessment Committee (PRAC): 23 - 26 November 202611/23/2026
  • Seventeenth meeting of the industry stakeholder platform on the operation of the centralised procedure for human medicines11/20/2026
  • EMA annual call with General Practitioner Organisations' representatives11/20/2026
  • Digitalisation and artificial intelligence in pharmaceutical manufacturing: Quality Innovation Group (QIG) - Follow-up roundtable meeting11/18/2026
  • Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - November 202611/18/2026

Get EMA (EU) alerts in your inbox as they are published.

Free plan, 2-minute setup, no credit card required.

RegulatoryAlerts Logo
RegulatoryAlerts

Automated regulatory intelligence monitoring for pharmaceutical and biotech professionals. Track FDA, EMA, and Health Canada updates seamlessly.

Product

  • Insights
  • Updates by Therapeutic Area
  • FDA Updates
  • EMA Updates
  • Pricing
  • Features
  • Request Demo

Resources

  • Integration Guides
  • Regulatory Glossary
  • EMA Timeline
  • Best Practices
  • Therapeutic Areas

Company

  • About Us
  • Blog
  • Contact
#immunogenicity
#efficacy
  • Security
  • Privacy Policy
  • Terms of Service
  • © 2026 RegulatoryAlerts. All rights reserved.

    Not affiliated with the FDA, EMA, or Health Canada.